M. Şansaçar Et Al. , "Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells," Medical Oncology , vol.41, no.1, 2024
Şansaçar, M. Et Al. 2024. Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells. Medical Oncology , vol.41, no.1 .
Şansaçar, M., Sağır, H., & GENCER AKÇOK, E. B., (2024). Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells. Medical Oncology , vol.41, no.1.
Şansaçar, MERVE, Helin Sağır, And EMEL BAŞAK GENCER AKÇOK. "Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells," Medical Oncology , vol.41, no.1, 2024
Şansaçar, MERVE Et Al. "Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells." Medical Oncology , vol.41, no.1, 2024
Şansaçar, M. Sağır, H. And GENCER AKÇOK, E. B. (2024) . "Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells." Medical Oncology , vol.41, no.1.
@article{article, author={MERVE ŞANSAÇAR Et Al. }, title={Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells}, journal={Medical Oncology}, year=2024}